These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22040647)

  • 1. [Use of intravitreal bevacizumab for the treatment of choroidal neovascularization secondary to choroidal rupture].
    Valldeperas X; Bonilla R; Romano MR; de la Cámara J
    Arch Soc Esp Oftalmol; 2011 Nov; 86(11):380-3. PubMed ID: 22040647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal bevacizumab injection in patients with choroidal neovascularization due to choroid rupture after blunt-head trauma.
    Artunay O; Rasier R; Yuzbasioglu E; Sengül A; Bahcecioglu H
    Int Ophthalmol; 2009 Aug; 29(4):289-91. PubMed ID: 18825317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal bevacizumab for extrafoveal choroidal neovascularization after ocular trauma.
    De Benedetto U; Battaglia Parodi M; Knutsson KA; Librando A; Bandello F; Lanzetta P; Iacono P
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):550-2. PubMed ID: 22554238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal bevacizumab for choroidal neovascularization associated with choroidal nevus.
    Chiang A; Bianciotto C; Maguire JI; Park CH; Baker PS; Shields JA; Shields CL
    Retina; 2012 Jan; 32(1):60-7. PubMed ID: 21886019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal bevacizumab therapy on an as-per-needed basis in subfoveal choroidal neovascularization secondary to pathological myopia: 2-year outcomes of a prospective case series.
    Iacono P; Parodi MB; Papayannis A; Kontadakis S; Sheth S; Bandello F
    Retina; 2011 Oct; 31(9):1841-7. PubMed ID: 21775926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravitreal injection of bevacizumab for CNV secondary to choroidal osteoma and follow-up by Spectral-Domain OCT].
    Mercé E; Korobelnik JF; Delyfer MN; Rougier MB
    J Fr Ophtalmol; 2012 Sep; 35(7):508-13. PubMed ID: 22695057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Juxtafoveal choroidal neovascularization associated with retinitis pigmentosa treated with intravitreal bevacizumab.
    Battaglia Parodi M; De Benedetto U; Knutsson KA; Scotti F; Librando A; Bandello F; Iacono P
    J Ocul Pharmacol Ther; 2012 Apr; 28(2):202-4. PubMed ID: 22149640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of three intravitreal injections of bevacizumab in the treatment of exudative age-related macular degeneration].
    Bidot ML; Malvitte L; Bidot S; Bron A; Creuzot-Garcher C
    J Fr Ophtalmol; 2011 Jun; 34(6):376-81. PubMed ID: 21550687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture.
    Barth T; Zeman F; Helbig H; Gamulescu MA
    BMC Ophthalmol; 2019 Nov; 19(1):239. PubMed ID: 31771544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term results of intravitreal bevacizumab injection for choroidal neovascularization secondary to angioid streaks.
    Sawa M; Gomi F; Tsujikawa M; Sakaguchi H; Tano Y
    Am J Ophthalmol; 2009 Oct; 148(4):584-590.e2. PubMed ID: 19541288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photoreceptor reconstitution correlates with visual improvement after intravitreal bevacizumab treatment of choroidal neovascularization secondary to traumatic choroidal rupture.
    Francis JH; Freund KB
    Retina; 2011 Feb; 31(2):422-4. PubMed ID: 21240036
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravitreal Bevacizumab for Traumatic Choroidal Rupture.
    Kim M; Kim JH; Seo Y; Koh HJ; Lee SC
    Optom Vis Sci; 2015 Oct; 92(10):e363-7. PubMed ID: 26367340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macular functional changes evaluated with MP-1 microperimetry after intravitreal bevacizumab for subfoveal myopic choroidal neovascularization: one-year results.
    Scupola A; Tiberti AC; Sasso P; Savastano MC; Mastrocola A; Marangoni D; Minnella AM; Falsini B; Balestrazzi E
    Retina; 2010 May; 30(5):739-47. PubMed ID: 20038860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaks: one year of follow-up.
    El Matri L; Kort F; Bouraoui R; Karim B; Chebil A; Chaker N
    Acta Ophthalmol; 2011 Nov; 89(7):641-6. PubMed ID: 21155980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration.
    Spaide RF; Laud K; Fine HF; Klancnik JM; Meyerle CB; Yannuzzi LA; Sorenson J; Slakter J; Fisher YL; Cooney MJ
    Retina; 2006 Apr; 26(4):383-90. PubMed ID: 16603955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study.
    Chan WM; Lai TY; Liu DT; Lam DS
    Ophthalmology; 2007 Dec; 114(12):2190-6. PubMed ID: 17599414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin.
    Chan WM; Lai TY; Liu DT; Lam DS
    Am J Ophthalmol; 2007 Jun; 143(6):977-983. PubMed ID: 17459318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal bevacizumab for subfoveal choroidal neovascularization secondary to traumatic choroidal rupture.
    Chanana B; Azad RV; Kumar N
    Eye (Lond); 2009 Nov; 23(11):2125-6. PubMed ID: 19169235
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravitreal bevacizumab as primary treatment of choroidal neovascularization secondary to punctate inner choroidopathy: results of a 1-year prospective trial.
    Zhang H; Liu ZL; Sun P; Gu F
    Retina; 2012 Jun; 32(6):1106-13. PubMed ID: 22481479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal bevacizumab to treat subfoveal choroidal neovascularisation in highly myopic eyes: 1-year outcome.
    Ruiz-Moreno JM; Montero JA; Gomez-Ulla F; Ares S
    Br J Ophthalmol; 2009 Apr; 93(4):448-51. PubMed ID: 19091851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.